Cargando…

Droplet Size and Distribution of Nebulized 3% Sodium Chloride, Albuterol, and Epoprostenol by Phase Doppler Particle Analyzer

BACKGROUND: Aerosolized drug therapy administered to mechanically ventilated patients is a standard part of pulmonary critical care medicine. Aerosol particle size and distribution are important factors in the optimal delivery of aerosolized drugs to ventilated patients. OBJECTIVE: The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDermott, Kelly, Oakley, Jason G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296146/ https://www.ncbi.nlm.nih.gov/pubmed/34306263 http://dx.doi.org/10.1016/j.curtheres.2021.100623

Ejemplares similares

Comparison of Nebulized Epinephrine to Albuterol in Bronchiolitis
por: Walsh, Paul, et al.
Publicado: (2008)

Physicochemical compatibility of fluticasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions
por: Kamin, Wolfgang, et al.
Publicado: (2007)

Size distributions of droplets produced by ultrasonic nebulizers
por: Kooij, Stefan, et al.
Publicado: (2019)

Bronchoscopy for foreign body aspiration and effects of nebulized albuterol and budesonide combination
por: Akcora, Bulent, et al.
Publicado: (2017)

The impact of nebulized epoprostenol and iloprost on hemoglobin oxygen affinity: an ex vivo experiment
por: Woyke, Simon, et al.
Publicado: (2022)

Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis
por: Beck, Raphael, et al.
Publicado: (2007)

Lactic acidosis and diastolic hypotension after intermittent albuterol nebulization in a pediatric patient
por: Saadia, Tehila A., et al.
Publicado: (2015)

Epoprostenol sodium for treatment of pulmonary arterial hypertension
por: Saito, Yukihiro, et al.
Publicado: (2015)

The effects of ventilator settings, nebulizer and exhalation port positions on albuterol delivery during noninvasive ventilation: an in vitro study
por: Sutherasan, Y, et al.
Publicado: (2015)

Microbial challenge test of a novel epoprostenol sodium formulation
por: Bandilla, Dirk, et al.
Publicado: (2017)

Effects of ventilator settings, nebulizer and exhalation port position on albuterol delivery during non-invasive ventilation: an in-vitro study
por: Sutherasan, Yuda, et al.
Publicado: (2017)

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma. A case report and literature review of airway effects of BAC
por: George, Mathew, et al.
Publicado: (2017)

Epoprostenol: Flushing or Erythroderma?
por: Martínez-Martínez, María Luisa, et al.
Publicado: (2013)

High-dose versus low-dose nebulized albuterol in acute asthmatic attack: a randomized double-blind clinical trial
por: Hosseinnezhad, A, et al.
Publicado: (2005)

In Vitro Characterization of Aerosolized Albuterol Generated by a Jet Nebulizer and Delivered through a Heated Flow Nasal Cannula System
por: Berlinski, Ariel, et al.
Publicado: (2022)

Epoprostenol Exposure During Pregnancy
por: Naoum, Emily E., et al.
Publicado: (2023)

Nebulized albuterol delivery is associated with decreased skeletal muscle strength in comparison with metered‐dose inhaler delivery among children with acute asthma exacerbations
por: Burger, Catherine, et al.
Publicado: (2021)

Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted
por: Lambert, Olivier, et al.
Publicado: (2012)

Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension
por: Lambert, Olivier, et al.
Publicado: (2012)

Exhaled Breath Condensate Detects Baseline Reductions in Chloride and Increases in Response to Albuterol in Cystic Fibrosis Patients
por: Wheatley, Courtney M., et al.
Publicado: (2013)

Epoprostenol: Exacerbation of thrombocytopenia : case report
Publicado: (2021)

Stress Cardiomyopathy Precipitated by Withdrawal of Epoprostenol
por: Gionfriddo, William J., et al.
Publicado: (2020)

Significant Lactic Acidosis from Albuterol
por: Hockstein, Maxwell, et al.
Publicado: (2018)

Subcutaneous terbutaline as an alternative to aerosolized albuterol
por: Strauss, Ronald A.
Publicado: (2020)

Hypertonic saline jet nebulization breathing treatments produce a predictable quantity of aerosolized sodium chloride for inhalation
por: Flores, Martin J., et al.
Publicado: (2022)

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
por: Donohue, James F., et al.
Publicado: (2016)

Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension
por: Mohammadi, Asma, et al.
Publicado: (2021)

Alteplase/epoprostenol: Lack of efficacy: case report
Publicado: (2022)

Epoprostenol‐associated ascites in pulmonary arterial hypertension
por: Schoenberg, Noah C., et al.
Publicado: (2022)

Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
por: Tamura, Yuichi, et al.
Publicado: (2013)

The Effects of Inhaled Albuterol in Transient Tachypnea of the Newborn
por: Kim, Myo-Jing, et al.
Publicado: (2014)

Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
por: Shaker, Marcus S., et al.
Publicado: (2020)

Evaluation of Renal Blood Flow in Dogs during Short-Term Human-Dose Epoprostenol Administration Using Pulsed Doppler and Contrast-Enhanced Ultrasonography
por: Hanazono, Kiwamu, et al.
Publicado: (2022)

Microscopic Droplet Size Analysis (MDSA) of “Five Thieves’ Oil” (Olejek Pięciu Złodziei) Essential Oil after the Nebulization Process
por: Smułek, Wojciech, et al.
Publicado: (2023)

Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
por: Tamura, Yuichi, et al.
Publicado: (2013)

Exhaled Air and Aerosolized Droplet Dispersion During Application of a Jet Nebulizer
por: Hui, David S., et al.
Publicado: (2009)

Visualization of droplet spread produced by a nebulizer during the COVID-19 pandemic
por: Kato, H, et al.
Publicado: (2021)

Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
por: Timofeev, Julia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_71o3i652348fs4sers38pi2bee